Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |